Search research articles
Contact Us
Filters
Showing results (481-490 of 525) with videos related to
Page
of 53
Sort By:
Nature Genetics
|
September 15, 2014
An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome
Scott W Canna, Adriana A de Jesus, Sushanth Gouni, et al.
Frontiers in Immunology
|
April 5, 2021
Spectrum of Systemic Auto-Inflammatory Diseases in India: A Multi-Centric Experience
Deepti Suri, Amit Rawat, Ankur Kumar Jindal, et al.
American Journal of Human Genetics
|
April 24, 2012
Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis
Catherine T Jordan, Li Cao, Elisha D O Roberson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 23, 2022
Antiviral innate immunity is diminished in the upper respiratory tract of severe COVID-19 patients
Marcos J Ramos-Benitez, Jeffrey R Strich, Sara Alehashemi, et al.
Annals of the Rheumatic Diseases
|
May 27, 2022
The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist
Micol Romano, Z Serap Arici, David Piskin, et al.
Arthritis and Rheumatism
|
December 17, 2002
De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases
Ivona Aksentijevich, Miroslawa Nowak, Mustapha Mallah, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 27, 2022
The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor Antagonist
Micol Romano, Z Serap Arici, David Piskin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 2018
Nitro-fatty acids are formed in response to virus infection and are potent inhibitors of STING palmitoylation and signaling
Anne Louise Hansen, Gregory J Buchan, Michael Rühl, et al.
Biorxiv : the Preprint Server for Biology
|
August 12, 2025
Spatial profiling reveals TREM2+ macrophages as central to Mycobacterium tuberculosis pathogenesis in human pulmonary tuberculosis
Rosane M Brandao Teles, Chaouki Benabdessalem, Jonathan Perrie, et al.
Annals of the Rheumatic Diseases
|
July 24, 2023
The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS)
Bita Shakoory, Ashley Geerlinks, Marta Wilejto, et al.
Page
of 53
Search research articles
Search
Showing results (481-490 of 525) with videos related to
Sort By:
Page
of 53
Nature Genetics
|
September 15, 2014
An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome
Scott W Canna, Adriana A de Jesus, Sushanth Gouni, et al.
Frontiers in Immunology
|
April 5, 2021
Spectrum of Systemic Auto-Inflammatory Diseases in India: A Multi-Centric Experience
Deepti Suri, Amit Rawat, Ankur Kumar Jindal, et al.
American Journal of Human Genetics
|
April 24, 2012
Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis
Catherine T Jordan, Li Cao, Elisha D O Roberson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 23, 2022
Antiviral innate immunity is diminished in the upper respiratory tract of severe COVID-19 patients
Marcos J Ramos-Benitez, Jeffrey R Strich, Sara Alehashemi, et al.
Annals of the Rheumatic Diseases
|
May 27, 2022
The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist
Micol Romano, Z Serap Arici, David Piskin, et al.
Arthritis and Rheumatism
|
December 17, 2002
De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases
Ivona Aksentijevich, Miroslawa Nowak, Mustapha Mallah, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 27, 2022
The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor Antagonist
Micol Romano, Z Serap Arici, David Piskin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 2018
Nitro-fatty acids are formed in response to virus infection and are potent inhibitors of STING palmitoylation and signaling
Anne Louise Hansen, Gregory J Buchan, Michael Rühl, et al.
Biorxiv : the Preprint Server for Biology
|
August 12, 2025
Spatial profiling reveals TREM2+ macrophages as central to Mycobacterium tuberculosis pathogenesis in human pulmonary tuberculosis
Rosane M Brandao Teles, Chaouki Benabdessalem, Jonathan Perrie, et al.
Annals of the Rheumatic Diseases
|
July 24, 2023
The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS)
Bita Shakoory, Ashley Geerlinks, Marta Wilejto, et al.
Page
of 53